EPHAMED financials
A multi-period view of the public annual-account figures reported for EPHAMED, with comparable measures and links to available source documents.
Company overviewRegistry number
0674631733
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for EPHAMED
2025 versus 2024
- Operating line
- €86,691
- EBITDA
- €85,965
- Total assets
- €113,433
- Equity
- €47,487
-24.2%
-24.5%
-18.8%
+22%
EBITDA margin +99.2% · Equity ratio +41.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €86,691 | €85,965 | €113,433 | €47,487 | - |
| 202431 Dec 2024 | €114,322 | €113,807 | €139,667 | €38,917 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.